Invesco Pharmaceuticals ETF
PJP
83 hedge funds and large institutions have $72.2M invested in Invesco Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 13 closing their positions.
2.84% less ownership
Funds ownership: 25.21% → 22.37% (-2.8%)
3% less funds holding
Funds holding: 86 → 83 (-3)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
20% less capital invested
Capital invested by funds: $89.7M → $72.2M (-$17.6M)
35% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWMS
Advocacy Wealth Management Services
Atlanta,
Georgia
|
+$3.67M |
| 2 |
FTUS
Flow Traders U.S.
New York
|
+$2.12M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.59M |
| 4 |
UR
USCA RIA
Houston,
Texas
|
+$1.16M |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$928K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$13.4M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$6.19M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.33M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.18M |
| 5 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
-$739K |
PJP Hedge Fund Activity: Q3 2020 in Review
83 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2020, worth a combined $72.2M — down 20% from $89.7M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PJP and 11 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 17 added.
The largest buyer was Advocacy Wealth Management Services, adding an estimated $3.67M. The largest seller was Brinker Capital Investments, cutting an estimated $13.4M.
- 83 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2020, down from 86 in Q2 2020.
- Funds reported $72.2M of Invesco Pharmaceuticals ETF stock for Q3 2020, down 20% quarter-over-quarter.
- 11 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2020 and 13 closed out, a net change of -2 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2020 was Advocacy Wealth Management Services, an estimated $3.67M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2020 was Brinker Capital Investments, an estimated $13.4M sold.
Based on aggregated 13F filings for Q3 2020.